交易 Bolt Biotherapeutics, Inc. - BOLT CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.0162 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 19, 2024 | 1.1069 | -0.0300 | -2.64% | 1.1369 | 1.1469 | 1.1069 |
Apr 18, 2024 | 1.1369 | 0.0300 | 2.71% | 1.1069 | 1.1469 | 1.0969 |
Apr 17, 2024 | 1.1069 | -0.0100 | -0.90% | 1.1169 | 1.1269 | 1.0969 |
Apr 16, 2024 | 1.1169 | 0.0000 | 0.00% | 1.1169 | 1.1369 | 1.0769 |
Apr 15, 2024 | 1.1269 | -0.0400 | -3.43% | 1.1669 | 1.1669 | 1.0969 |
Apr 12, 2024 | 1.1769 | -0.0700 | -5.61% | 1.2469 | 1.2669 | 1.1569 |
Apr 11, 2024 | 1.2469 | 0.0100 | 0.81% | 1.2369 | 1.2569 | 1.2369 |
Apr 10, 2024 | 1.2469 | -0.0100 | -0.80% | 1.2569 | 1.2669 | 1.2169 |
Apr 9, 2024 | 1.2669 | -0.0500 | -3.80% | 1.3169 | 1.3169 | 1.2369 |
Apr 8, 2024 | 1.3669 | 0.0000 | 0.00% | 1.3669 | 1.3669 | 1.2969 |
Apr 5, 2024 | 1.3269 | -0.0400 | -2.93% | 1.3669 | 1.3669 | 1.3069 |
Apr 4, 2024 | 1.3169 | -0.0100 | -0.75% | 1.3269 | 1.3469 | 1.3069 |
Apr 3, 2024 | 1.3269 | -0.0300 | -2.21% | 1.3569 | 1.4569 | 1.2869 |
Apr 2, 2024 | 1.3769 | -0.0300 | -2.13% | 1.4069 | 1.4569 | 1.3269 |
Apr 1, 2024 | 1.4869 | 0.0900 | 6.44% | 1.3969 | 1.5469 | 1.3369 |
Mar 28, 2024 | 1.3769 | 0.1700 | 14.09% | 1.2069 | 1.4569 | 1.2069 |
Mar 27, 2024 | 1.1969 | 0.0300 | 2.57% | 1.1669 | 1.2069 | 1.1669 |
Mar 26, 2024 | 1.1769 | -0.0200 | -1.67% | 1.1969 | 1.2069 | 1.1469 |
Mar 25, 2024 | 1.1769 | 0.0200 | 1.73% | 1.1569 | 1.1969 | 1.1569 |
Mar 22, 2024 | 1.1669 | 0.0100 | 0.86% | 1.1569 | 1.1769 | 1.1469 |
Bolt Biotherapeutics, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Tuesday, April 23, 2024 | ||
時間 (UTC) 15:00 | 國家 US
| 事件 Bolt Biotherapeutics Inc Annual Shareholders Meeting Bolt Biotherapeutics Inc Annual Shareholders MeetingForecast(預報) -返回 - |
Thursday, May 9, 2024 | ||
時間 (UTC) 10:59 | 國家 US
| 事件 Q1 2024 Bolt Biotherapeutics Inc Earnings Release Q1 2024 Bolt Biotherapeutics Inc Earnings ReleaseForecast(預報) -返回 - |
Monday, August 5, 2024 | ||
時間 (UTC) 10:59 | 國家 US
| 事件 Q2 2024 Bolt Biotherapeutics Inc Earnings Release Q2 2024 Bolt Biotherapeutics Inc Earnings ReleaseForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 5.729 | 1.26 | 0.231 | 0.215 | 0 |
收入 | 5.729 | 1.26 | 0.231 | 0.215 | 0 |
總營業費用 | 96.05 | 94.048 | 49.413 | 31.184 | 11.629 |
銷售/一般/行政費用,總計 | 22.927 | 18.393 | 9.056 | 5.182 | 2.209 |
研究與開發 | 73.123 | 75.655 | 40.357 | 26.002 | 9.42 |
營業收入 | -90.321 | -92.788 | -49.182 | -30.969 | -11.629 |
利息收入(費用),非經營淨值 | 2.223 | 0.281 | 0.199 | 0.524 | 0.193 |
其他,淨值 | 0 | -6.084 | -11.745 | -0.042 | -0.153 |
稅前淨收入 | -88.098 | -98.591 | -60.728 | -30.487 | -11.589 |
稅後淨收入 | -88.098 | -98.591 | -60.728 | -30.487 | -11.589 |
未計算非常項目前的淨收益 | -88.098 | -98.591 | -60.728 | -30.487 | -11.589 |
淨收入 | -88.098 | -98.591 | -60.728 | -30.487 | -11.589 |
普通股股東可獲收益 (不含非經常性項目) | -88.098 | -98.591 | -60.728 | -30.487 | -11.589 |
普通股股東可獲收益 (含非經常性項目) | -88.098 | -98.591 | -60.728 | -30.487 | -11.589 |
攤薄淨收入 | -88.098 | -98.591 | -60.728 | -30.487 | -11.589 |
攤薄後加權平均股 | 37.3584 | 37.3997 | 36.3279 | 34.5218 | 34.5218 |
扣除特別項目的每股攤薄盈利 | -2.35818 | -2.63614 | -1.67166 | -0.88312 | -0.3357 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
每股正常攤薄盈利 | -2.35818 | -2.63614 | -1.67166 | -0.88312 | -0.3357 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 1.433 | 1.826 | 1.411 | 2.112 | 1.393 |
收入 | 1.433 | 1.826 | 1.411 | 2.112 | 1.393 |
總營業費用 | 21.265 | 20.241 | 22.451 | 24.458 | 24.452 |
銷售/一般/行政費用,總計 | 5.621 | 5.616 | 5.606 | 5.485 | 5.532 |
研究與開發 | 15.644 | 14.625 | 16.845 | 18.973 | 18.92 |
營業收入 | -19.832 | -18.415 | -21.04 | -22.346 | -23.059 |
利息收入(費用),非經營淨值 | 1.775 | 1.435 | 1.043 | 0.587 | 0.395 |
其他,淨值 | 0 | 0 | 0 | ||
稅前淨收入 | -18.057 | -16.98 | -19.997 | -21.759 | -22.664 |
稅後淨收入 | -18.057 | -16.98 | -19.997 | -21.759 | -22.664 |
未計算非常項目前的淨收益 | -18.057 | -16.98 | -19.997 | -21.759 | -22.664 |
淨收入 | -18.057 | -16.98 | -19.997 | -21.759 | -22.664 |
普通股股東可獲收益 (不含非經常性項目) | -18.057 | -16.98 | -19.997 | -21.759 | -22.664 |
普通股股東可獲收益 (含非經常性項目) | -18.057 | -16.98 | -19.997 | -21.759 | -22.664 |
攤薄淨收入 | -18.057 | -16.98 | -19.997 | -21.759 | -22.664 |
攤薄後加權平均股 | 37.7504 | 37.684 | 37.5543 | 37.4543 | 37.2936 |
扣除特別項目的每股攤薄盈利 | -0.47833 | -0.45059 | -0.53248 | -0.58095 | -0.60772 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.47833 | -0.45059 | -0.53248 | -0.58095 | -0.60772 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 172.746 | 189.16 | 25.361 | 35.9 | 14.1 |
現金和短期投資 | 168.888 | 186.219 | 22.838 | 34.826 | 13.634 |
現金等價物 | 9.244 | 27.383 | 5.542 | 34.826 | 13.634 |
短期投資 | 159.644 | 158.836 | 17.296 | 0 | 0 |
預付的費用 | 3.858 | 2.941 | 2.523 | 1.074 | 0.466 |
總資産 | 227.807 | 307.718 | 46.542 | 48.447 | 15.975 |
物業/廠房/設備,總計 - 淨額 | 28.525 | 30.603 | 16.384 | 11.517 | 1.442 |
物業/廠房/設備,總計 - 總額 | 32.44 | 32.848 | 17.623 | 12.162 | 1.856 |
累計折舊,總計 | -3.915 | -2.245 | -1.239 | -0.645 | -0.414 |
其他長期資産,總計 | 2.593 | 2.607 | 4.797 | 1.03 | 0.433 |
流動負債總額 | 23.118 | 21.328 | 11.264 | 8.656 | 2.755 |
應付賬款 | 3.594 | 3.574 | 1.598 | 2.095 | 0.892 |
預提費用 | 17.531 | 14.885 | 8.164 | 5.962 | 1.823 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 0 | 0.04 | |||
其他流動負債,總計 | 1.993 | 2.869 | 1.502 | 0.599 | 0 |
負債總額 | 56.301 | 57.599 | 46.193 | 16.788 | 3.551 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 33.183 | 36.271 | 34.929 | 8.132 | 0.796 |
股權 | 171.506 | 250.119 | 0.349 | 31.659 | 12.424 |
Preferred Stock - Non Redeemable, Net | 105.296 | 77.505 | 28.367 | ||
普通股 | 0.00038 | 0.00037 | 0.00036 | 0 | 0 |
額外實收資本 | 467.513 | 457.43 | 3.452 | 1.825 | 1.241 |
留存收益(累計赤字) | -295.088 | -206.99 | -108.399 | -47.671 | -17.184 |
其他權益,總計 | -0.91938 | -0.32137 | -0.00036 | 0 | 0 |
總負債和股東權益 | 227.807 | 307.718 | 46.542 | 48.447 | 15.975 |
已發行普通股總數 | 37.7979 | 37.3997 | 36.3279 | 34.5218 | 34.5218 |
長期投資 | 23.943 | 85.348 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 125.466 | 130.668 | 131.609 | 172.746 | 174.826 |
現金和短期投資 | 119.724 | 125.866 | 126.379 | 168.888 | 171.13 |
現金等價物 | 9.16 | 13.451 | 14.836 | 9.244 | 10.617 |
短期投資 | 110.564 | 112.415 | 111.543 | 159.644 | 160.513 |
預付的費用 | 5.742 | 4.802 | 5.23 | 3.858 | 3.696 |
總資産 | 175.355 | 190.696 | 206.181 | 227.807 | 245.505 |
物業/廠房/設備,總計 - 淨額 | 25.144 | 26.231 | 27.388 | 28.525 | 29.682 |
物業/廠房/設備,總計 - 總額 | 30.435 | 31.071 | 31.769 | 32.44 | 33.135 |
累計折舊,總計 | -5.291 | -4.84 | -4.381 | -3.915 | -3.453 |
長期投資 | 21.638 | 31.22 | 44.586 | 23.943 | 38.432 |
其他長期資産,總計 | 3.107 | 2.577 | 2.598 | 2.593 | 2.565 |
流動負債總額 | 18.751 | 17.618 | 16.253 | 23.118 | 24.174 |
應付賬款 | 3.682 | 3.436 | 1.835 | 3.594 | 3.828 |
預提費用 | 13.131 | 12.497 | 12.818 | 17.531 | 17.177 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 1.938 | 1.685 | 1.6 | 1.993 | 3.169 |
負債總額 | 47.096 | 48.564 | 48.495 | 56.301 | 57.059 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 28.345 | 30.946 | 32.242 | 33.183 | 32.885 |
股權 | 128.259 | 142.132 | 157.686 | 171.506 | 188.446 |
Preferred Stock - Non Redeemable, Net | |||||
普通股 | 0.001 | 0.001 | 0.00038 | 0.00038 | 0.00038 |
額外實收資本 | 474.814 | 472.485 | 469.989 | 467.513 | 465.246 |
留存收益(累計赤字) | -346.382 | -330.125 | -312.068 | -295.088 | -275.091 |
其他權益,總計 | -0.174 | -0.229 | -0.23538 | -0.91938 | -1.70938 |
總負債和股東權益 | 175.355 | 190.696 | 206.181 | 227.807 | 245.505 |
已發行普通股總數 | 37.9659 | 37.951 | 37.813 | 37.7979 | 37.6609 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -88.098 | -98.591 | -60.728 | -30.487 | -11.589 |
經營活動産生的現金 | -76.504 | -57.066 | -47.308 | -26.343 | -9.872 |
經營活動産生的現金 | 1.666 | 1.193 | 0.611 | 0.335 | 0.302 |
非現金物品 | 12.985 | 19.825 | 15.092 | 1.544 | 0.276 |
已付現金利息 | 0 | 0.004 | |||
營運資金的變化 | -3.057 | 20.507 | -2.283 | 2.265 | 1.139 |
投資活動産生的現金 | 57.862 | -232.201 | -20.592 | -0.508 | -0.29 |
資本支出 | -1.953 | -2.338 | -3.262 | -0.508 | -0.29 |
其他投資現金流量項目,總計 | 59.815 | -229.863 | -17.33 | 0 | 0 |
融資活動産生的現金 | 0.503 | 311.108 | 39.597 | 48.627 | 19.094 |
融資現金流項目 | 0 | 0 | 39.303 | 48.595 | 19.113 |
股票的發行(報廢),淨額 | 0.503 | 311.108 | 0.294 | 0.072 | 0.02 |
債務的發行(退還),淨額 | 0 | -0.04 | -0.039 | ||
現金淨變化 | -18.139 | 21.841 | -28.303 | 21.776 | 8.932 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -16.98 | -88.098 | -68.101 | -46.342 | -23.678 |
Cash From Operating Activities | -23.399 | -76.504 | -58.552 | -45.101 | -24.314 |
Cash From Operating Activities | 0.467 | 1.666 | 1.204 | 0.765 | 0.357 |
Non-Cash Items | 2.343 | 12.985 | 10.628 | 7.841 | 4.556 |
Changes in Working Capital | -9.229 | -3.057 | -2.283 | -7.365 | -5.549 |
Cash From Investing Activities | 28.991 | 57.862 | 41.427 | 39.977 | 40.845 |
Capital Expenditures | -0.003 | -1.953 | -1.769 | -1.034 | -0.605 |
Other Investing Cash Flow Items, Total | 28.994 | 59.815 | 43.196 | 41.011 | 41.45 |
Cash From Financing Activities | 0 | 0.503 | 0.359 | 0.359 | 0.107 |
Issuance (Retirement) of Stock, Net | 0 | 0.503 | 0.359 | 0.359 | 0.107 |
Net Change in Cash | 5.592 | -18.139 | -16.766 | -4.765 | 16.638 |
Financing Cash Flow Items | 0 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Bio Therapeutic Drugs |
900 Chesapeake Drive
REDWOOD CITY
CALIFORNIA 94063
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易